EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
How EY can help
-
With decades of experience helping companies go public, our IPO readiness assessment team can help you get ready for the big day — and beyond. Learn how.
Read more
The US IPO market: Q3 2024 in review
Following a spike in volatility in early August, the market regained its composure, with valuations rebounding and volatility retreating. Twelve deals raised more than $100m in Q3, including the largest IPO of the year globally that raised more than $5b.
IPO proceeds over the first three quarters of 2024 have already outpaced 2023’s full-year levels. Thus far in 2024, 121 IPOs on US exchanges have raised $27.3b; 17 deals have raised more than $500m, more than double the total for the entire year in 2023. Several of the larger deals on US exchanges were for non-US companies — and significant IPO readiness efforts are underway by companies around the world planning to seek listings in the US in the coming quarters and years.
On one end of the spectrum, the largely pre-revenue biotech sector has been active as sector indexes have rallied from last fall’s lows; on the other end of the spectrum, IPO investors continue to favor larger, more scaled and profitable companies. A broader market rally for small- and mid-cap growth companies as interest rates decline could open up the IPO market for more traditional growth stage companies to seek listings.